OBI Volunteers Actively Participated in TBCA’s Pink October Event to Support Breast Cancer Awareness and Prevention

OBI Chairman Dr. Kung-Yee Liang Receives the 2024–2025 Presidential Science Prize

OBI Invited to Present ADC Technology Platform and Chaired Sessions at Biologics World Korea 2025

Announcement for the expected date of the Board of Directors Meeting for 2025Q3 consolidated financial report is 2025/11/10

Announcement to creditors of the Company for conducting capital reduction to make up for losses.

Announcement of the Company’s important resolutions of the 2025 First Extraordinary General Shareholders’ meeting.

2024 Annual Report

Learn how we created value in 2024 and worked to pursue our purpose of enabling a healthier world.

Governance

Corporate
Overview​

Board of
Directors​

Special ​
Committee​

Integrity​

Internal
Audit​

Governance
Document​

Investor Relations